Inditel AM Tablet is a combination antihypertensive medication containing Telmisartan 40 mg and Amlodipine 5 mg, designed for the effective management of hypertension. Telmisartan, an angiotensin II receptor blocker (ARB), works by selectively inhibiting the binding of angiotensin II to the AT1 receptor, resulting in vasodilation and reduced secretion of aldosterone, thereby lowering blood pressure. Amlodipine, a calcium channel blocker (CCB), inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle, promoting vasodilation and reducing peripheral vascular resistance. The synergistic action of these two agents provides enhanced blood pressure control compared to monotherapy, improving cardiovascular outcomes and reducing the risk of stroke, myocardial infarction, and other hypertensive complications. Inditel AM is indicated for patients who require multiple antihypertensive agents to achieve adequate blood pressure control. It is generally well-tolerated, with common adverse effects including dizziness, peripheral edema, and fatigue. Caution is advised in patients with hepatic or renal impairment, and it should be used under medical supervision with periodic monitoring of blood pressure and renal function. Inditel AM Tablet offers a convenient once-daily dosing regimen to improve patient compliance in hypertension management.